JMPWA
ALXO icon

JP Morgan Private Wealth Advisors’s ALX Oncology ALXO Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$96K Buy
+20,000
New +$109K ﹤0.01% 1686

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ALXO Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors opened a new position in ALX Oncology (ALXO) in Q3 2023: 20,000 shares worth $96K. The stake represents ﹤0.01% of the portfolio and ranks #1686 among its holdings.

76 funds tracked by Wall St. Rank hold ALXO as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 20,000 shares of ALX Oncology worth $96K as of Q3 2023.
  • ALX Oncology was a new JP Morgan Private Wealth Advisors position in Q3 2023.
  • ALX Oncology made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1686 holding.
  • 76 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.